LRMR - Larimar Therapeutics GAAP EPS of -$0.61 misses by $0.21
2025-11-05 12:28:51 ET
More on Larimar Therapeutics
- Larimar Therapeutics, Inc. (LRMR) Discusses On The Nomlabofusp Program For The Treatment Of Friedreich's Ataxia Conference Call (Transcript)
- Seeking Alpha’s Quant Rating on Larimar Therapeutics
- Historical earnings data for Larimar Therapeutics
- Financial information for Larimar Therapeutics